Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA 2005 Resolutions: Faster Pre-Approval Audits, Fully Trained AP Inspectors

This article was originally published in The Silver Sheet

Executive Summary

MDUFMA IMPLEMENTATION ACTIVITIES AT FDA include new timelines for GMP pre-approval inspections, fresh efforts to get the Accredited Persons third-party inspection program off the ground, and an all-out campaign by agency officials to prevent automatic termination of user fees in October 2005. Industry groups reiterate need to stabilize fee increases. Meanwhile, FDA moves to ensure compliance by single-use device reprocessors in wake of cleaning validation review, while original equipment manufacturers urge even tougher action

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT036095

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel